Xylem (NYSE:XYL) Price Target Increased to $170.00 by Analysts at Stifel Nicolaus

Xylem (NYSE:XYL) had its price objective hoisted by Stifel Nicolaus from $157.00 to $170.00 in a research report released on Thursday morning, Benzinga reports. Stifel Nicolaus currently has a buy rating on the industrial products company’s stock.

A number of other research firms have also recently weighed in on XYL. Mizuho increased their price objective on shares of Xylem from $110.00 to $135.00 and gave the stock a neutral rating in a report on Friday, May 3rd. Royal Bank of Canada raised their target price on shares of Xylem from $157.00 to $162.00 and gave the company an outperform rating in a research note on Friday, May 3rd. Argus raised their target price on shares of Xylem from $146.00 to $165.00 and gave the company a buy rating in a research note on Wednesday, May 29th. Robert W. Baird raised their target price on shares of Xylem from $151.00 to $155.00 and gave the company an outperform rating in a research note on Friday, May 3rd. Finally, Oppenheimer raised their target price on shares of Xylem from $147.00 to $152.00 and gave the company an outperform rating in a research note on Friday, May 31st. Five research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, Xylem currently has a consensus rating of Moderate Buy and an average target price of $144.58.

Xylem Stock Down 0.4 %

XYL stock opened at $137.49 on Thursday. The company has a quick ratio of 1.22, a current ratio of 1.67 and a debt-to-equity ratio of 0.19. Xylem has a fifty-two week low of $87.59 and a fifty-two week high of $146.08. The firm’s 50-day simple moving average is $138.92 and its 200 day simple moving average is $129.60. The stock has a market cap of $33.33 billion, a PE ratio of 48.93, a price-to-earnings-growth ratio of 2.44 and a beta of 1.04.

Xylem (NYSE:XYL) last released its quarterly earnings data on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.06. Xylem had a net margin of 8.34% and a return on equity of 8.95%. The business had revenue of $2.03 billion for the quarter, compared to analysts’ expectations of $2 billion. During the same quarter last year, the company earned $0.72 EPS. The company’s revenue for the quarter was up 40.4% compared to the same quarter last year. As a group, sell-side analysts predict that Xylem will post 4.22 EPS for the current year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 27th. Stockholders of record on Thursday, May 30th were given a dividend of $0.36 per share. The ex-dividend date was Thursday, May 30th. This represents a $1.44 annualized dividend and a dividend yield of 1.05%. Xylem’s dividend payout ratio (DPR) is 51.25%.

Insider Activity

In other news, SVP Rodney Aulick sold 21,800 shares of the firm’s stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the completion of the transaction, the senior vice president now owns 76,287 shares in the company, valued at approximately $10,604,655.87. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other Xylem news, CAO Geri-Michelle Mcshane sold 2,278 shares of the firm’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $138.63, for a total value of $315,799.14. Following the completion of the transaction, the chief accounting officer now directly owns 3,536 shares in the company, valued at $490,195.68. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Rodney Aulick sold 21,800 shares of the firm’s stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the completion of the transaction, the senior vice president now owns 76,287 shares of the company’s stock, valued at $10,604,655.87. The disclosure for this sale can be found here. Insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. EverSource Wealth Advisors LLC boosted its holdings in shares of Xylem by 68.8% in the first quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock worth $25,000 after buying an additional 77 shares during the period. Bruce G. Allen Investments LLC acquired a new position in shares of Xylem in the fourth quarter worth about $27,000. Blue Trust Inc. boosted its holdings in shares of Xylem by 1,185.7% in the second quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock worth $35,000 after buying an additional 249 shares during the period. FinTrust Capital Advisors LLC boosted its holdings in shares of Xylem by 170.9% in the first quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock worth $41,000 after buying an additional 200 shares during the period. Finally, Hazlett Burt & Watson Inc. boosted its holdings in shares of Xylem by 184.9% during the first quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock worth $43,000 after purchasing an additional 220 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.